Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

Overview of attention for article published in International Journal of Nanomedicine, August 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

googleplus: 1 Google+ user

Citations

dimensions_citation: 67 Dimensions

Readers on

mendeley: 65 Mendeley

Summary X Patents Google+ Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Tumor cell-specific responsive self-assembling drug nanoconjugate

Grant US-10610602-B2

United States of America